MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.
The discovery of TAF15 amyloid filaments in patients with frontotemporal lobar degeneration by the group of Benjamin Ryskeldi-Falcon in the LMB’s Neurobiology Division establishes this protein as a diagnostic and therapeutic target for this neurodegenerative disorder.
A collaborative team lead by Chris Russo’s group in the LMB’s Structural Studies Division has developed a new electron cryo-microscope, capable of solving atomic structures at a fraction of the energy and cost of existing models.
The entire wireless neuropeptide signalling network of a whole animal, the nematode worm C. elegans, has been mapped for the first time by William Schafer’s group in the LMB’s Neurobiology Division and collaborators.
A collaboration between the groups of Emmanuel Derivery, and John O’Neill in the LMB’s Cell Biology Division, and Rachel Edgar’s group at Imperial College London, have discovered a rapid mechanism by which cells ensure that an optimal balance of water is available for biochemical reactions and protein structure and function.
Philipp Holliger and Ben Porebski in the LMB’s PNAC Division, in collaboration with AstraZeneca, have developed a new ultra-high-throughput method that shows promise to accelerate antibody discovery for a wide range of targets.
Emmanuel Derivery’s group, in the LMB’s Cell Biology Division, has developed a method to directly untangle the contribution of any signalling pathway involved in asymmetric cell division.